Corminboeuf; Olivier
Patent Applications and Registrations
Patent applications and USPTO patent grants for Corminboeuf; Olivier.The latest application filed is for "n-substituted indole derivatives as pge2 receptor modulators".
Company Profile
5.28.31
- Corminboeuf; Olivier - Allschwil CH
- Corminboeuf; Olivier - Allschwill CH
Patent Activity
| Patent | Date |
|---|---|
| Pyrimidine derivatives Grant 11,446,298 - Boss , et al. September 20, 2 | 2022-09-20 |
| N-substituted Indole Derivatives As Pge2 Receptor Modulators App 20220175775 - FRETZ; Heinz ; et al. | 2022-06-09 |
| Benzofurane and benzothiophene derivatives as PGE2 receptor modulators Grant 11,325,899 - Boss , et al. May 10, 2 | 2022-05-10 |
| N-substituted indole derivatives as PGE2 receptor modulators Grant 11,241,431 - Fretz , et al. February 8, 2 | 2022-02-08 |
| Benzofurane And Benzothiophene Derivatives As Pge2 Receptor Modulators App 20210115031 - BOSS; Christoph ; et al. | 2021-04-22 |
| Pyrimidine Derivatives As Pge2 Receptor Modulators App 20210113559 - BOSS; Christoph ; et al. | 2021-04-22 |
| N-substituted Indole Derivatives As Pge2 Receptor Modulators App 20200289507 - FRETZ; Heinz ; et al. | 2020-09-17 |
| Phenyl Derivatives As Pge2 Receptor Modulators App 20200179383 - BOSS; Christoph ; et al. | 2020-06-11 |
| Pyrimidine Derivatives App 20200108068 - BOSS; Christoph ; et al. | 2020-04-09 |
| Difluoroethyl-oxazole substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists Grant 9,676,761 - Corminboeuf , et al. June 13, 2 | 2017-06-13 |
| Benzimidazolyl-methyl urea derivatives as ALX receptor agonists Grant 9,663,473 - Corminboeuf , et al. May 30, 2 | 2017-05-30 |
| Piperazine substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists Grant 9,533,964 - Corminboeuf , et al. January 3, 2 | 2017-01-03 |
| Difluoroethyl-oxazole sustituted bridged spiro[2.4]heptane derivatives as alx receptor agonists App 20160289221 - Corminboeuf; Olivier ; et al. | 2016-10-06 |
| Benzimidazolyl-methyl Urea Derivatives As Alx Receptor Agonists App 20160200686 - CORMINBOEUF; Olivier ; et al. | 2016-07-14 |
| Piperazine Substituted Bridged Spiro[2.4]heptane Derivatives As Alx Receptor Agonists App 20160152584 - CORMINBOEUF; Olivier ; et al. | 2016-06-02 |
| Hydroxylated aminotriazole derivatives as ALX receptor agonists Grant 9,346,793 - Bur , et al. May 24, 2 | 2016-05-24 |
| 1-(p-tolyl) cyclopropyl substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists Grant 9,284,288 - Corminboeuf , et al. March 15, 2 | 2016-03-15 |
| Bridged Spiro[2.4]heptane ester derivatives Grant 9,187,435 - Bur , et al. November 17, 2 | 2015-11-17 |
| Fluorinated bridged spiro[2.4]heptane derivatives as ALX receptor agonists Grant 9,139,524 - Corminboeuf , et al. September 22, 2 | 2015-09-22 |
| 1-(p-tolyl)cyclopropyl substituted Bridged Spiro[2.4]Heptane Derivatives as ALX Receptor Agonists App 20150141482 - Corminboeuf; Olivier ; et al. | 2015-05-21 |
| Fluorinated Bridged Spiro[2.4]Heptane Derivatives as ALX Receptor Agonists App 20150118258 - Corminboeuf; Olivier ; et al. | 2015-04-30 |
| Piperazines as antimalarial agents Grant 8,889,688 - Aissaoui , et al. November 18, 2 | 2014-11-18 |
| Oxazolyl-methylether derivatives as ALX receptor agonists Grant 8,846,733 - Bur , et al. September 30, 2 | 2014-09-30 |
| Oxazole and thiazole derivatives as ALX receptor agonists Grant 8,674,111 - Bur , et al. March 18, 2 | 2014-03-18 |
| Fluorinated aminotriazole derivatives Grant 8,580,831 - Bur , et al. November 12, 2 | 2013-11-12 |
| Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists Grant 8,563,714 - Bur , et al. October 22, 2 | 2013-10-22 |
| Hydroxylated Aminotriazole Derivatives as ALX Receptor Agonists App 20130267569 - Bur; Daniel ; et al. | 2013-10-10 |
| Oxazolyl-methylether Derivatives As Alx Receptor Agonists App 20130261159 - Bur; Daniel ; et al. | 2013-10-03 |
| Aminotriazole derivatives as ALX agonists Grant 8,536,209 - Bur , et al. September 17, 2 | 2013-09-17 |
| Piperazines As Antimalarial Agents App 20120316178 - Aissaoui; Hamed ; et al. | 2012-12-13 |
| Bridged Spiro [2.4] Heptane Derivatives As Alx Receptor And/or Fprl2 Agonists App 20120115841 - Bur; Daniel ; et al. | 2012-05-10 |
| Oxazole And Thiazole Derivatives As Alx Receptor Agonists App 20120115916 - Bur; Daniel ; et al. | 2012-05-10 |
| Fluorinated Aminotriazole Derivatives App 20120101138 - Bur; Daniel ; et al. | 2012-04-26 |
| Bicyclononene derivatives Grant 8,138,340 - Bezencon , et al. March 20, 2 | 2012-03-20 |
| Piperazines as antimalarial agents Grant 8,067,419 - Binkert , et al. November 29, 2 | 2011-11-29 |
| Tetrahydroisoquinolines As Antimalarial Agents App 20110281869 - Aissaoui; Hamed ; et al. | 2011-11-17 |
| Novel Bis-amides As Anti-malarial Agents App 20110224210 - Aissaoui; Hamed ; et al. | 2011-09-15 |
| Secondary amines as renin inhibitors Grant 7,968,720 - Bezencon , et al. June 28, 2 | 2011-06-28 |
| Aminopyrazole Derivatives App 20110034516 - Bur; Daniel ; et al. | 2011-02-10 |
| Aminotriazole Derivatives As Alx Agonists App 20100331378 - Bur; Daniel ; et al. | 2010-12-30 |
| Novel Piperidine Carboxylic Acid Amine Derivatives App 20100324052 - Bezencon; Olivier ; et al. | 2010-12-23 |
| Piperidine carboxylic acid amide derivatives Grant 7,799,805 - Bezencon , et al. September 21, 2 | 2010-09-21 |
| Bicyclononene derivaties App 20090306123 - Bezencon; Olivier ; et al. | 2009-12-10 |
| Secondary Amines as Renin Inhibitors App 20090176823 - Bezencon; Olivier ; et al. | 2009-07-09 |
| Primary Amines as Renin Inhibitors App 20090088457 - Bezencon; Olivier ; et al. | 2009-04-02 |
| Amines App 20090062342 - Bezencon; Olivier ; et al. | 2009-03-05 |
| Novel Piperazines as Antimalarial Agents App 20080234272 - Binkert; Christoph ; et al. | 2008-09-25 |
| Novel Piperidine Carboxylic Acid Amide Derivatives App 20080214598 - Bezencon; Olivier ; et al. | 2008-09-04 |
| Novel 4-Aminopiperidine Derivatives App 20080076762 - Boss; Christoph ; et al. | 2008-03-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 